Muller Lorenz 4
4 · Milestone Pharmaceuticals Inc. · Filed Aug 28, 2020
Insider Transaction Report
Form 4
Muller Lorenz
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2020-08-26$1.54/sh+5,700$8,778→ 108,386 total - Exercise/Conversion
Employee Stock Option (right to buy)
2020-08-26−5,700→ 49,754 totalExercise: $1.54Exp: 2027-10-11→ Common Stock (5,700 underlying)
Footnotes (1)
- [F1]The original grant was for 140,100 option shares. Twenty-five percent (25%) of the shares subject to the option vested on October 11, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.